Early Detection Research Network

Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening.

No abstract available.

Ankerst DP, Choate K, Gelfond J, Hernandez J, Leach RJ, Thompson IM

25686543

J. Urol., 2015, 194 (1)